Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study.

PLoS One · 2024 · PMC11309412 · PMID 39116084

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Sensitivity analysis excluding patients with prior MI or ischemic stroke showed fewer MACE with GLP-1-RA exposure, but this did not reach statistical significance (weighted HR: 0.72 [0.49–1.05]; RD: -7.0 [-16.1 to 2.2]).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.